We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

253 hedge funds and large institutions have $20.4B invested in BeOne Medicines Ltd in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 79 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 79

7% more capital invested

Capital invested by funds: $19.1B → $20.4B (+$1.32B)

0.01% more ownership

Funds ownership: 4.65% → 4.67% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 11 → 11 (0)

5% less funds holding

Funds holding: 266 → 253 (-13)

24% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 37

32% less call options, than puts

Call options by funds: $31.3M | Put options by funds: $46M

Holders
253
Holders Change
-13
Holders Change %
-4.89%
% of All Funds
4.43%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
28
Increased
97
Reduced
79
Closed
37
Calls
$31.3M
Puts
$46M
Net Calls
-$14.7M
Net Calls Change
-$13.4M

Top Buyers

1
Invesco
Invesco
Georgia
+$190M
2
PIF
Public Investment Fund
Saudi Arabia
+$162M
3
Capital International Investors
Capital International Investors
California
+$126M
4
Norges Bank
Norges Bank
Norway
+$108M
5
Temasek Holdings
Temasek Holdings
Singapore
+$54.4M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$156M
2
RSCM
Rock Springs Capital Management
Maryland
-$68.6M
3
AG
Artal Group
Luxembourg
-$65.4M
4
CBT
Capital Bank & Trust
California
-$53.7M
5
DCM
Driehaus Capital Management
Illinois
-$52.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$62.6M -$17.8M -54,465 -24%
Goldman Sachs
27
Goldman Sachs
New York
$59.4M -$48.8M -149,171 -48%
CGPCS
28
Capital Group Private Client Services
California
$58.8M +$53M +161,980 New
BNP Paribas Asset Management
29
BNP Paribas Asset Management
France
$57M +$29.9M +91,527 +140%
CC
30
Casdin Capital
New York
$54.5M – – –
Mitsubishi UFJ Trust & Banking
31
Mitsubishi UFJ Trust & Banking
Japan
$52.8M -$3.62M -11,078 -7%
Fiera Capital (Canada)
32
Fiera Capital (Canada)
Quebec, Canada
$52.7M -$837K -2,559 -2%
Mirae Asset Global Investments
33
Mirae Asset Global Investments
South Korea
$49.5M -$7.29M -22,300 -14%
CS
34
Candriam SCA
Luxembourg
$49.5M +$1.86M +5,686 +4%
Morgan Stanley
35
Morgan Stanley
New York
$46.4M +$4.39M +13,422 +12%
Northern Trust
36
Northern Trust
Illinois
$44.5M -$25M -76,320 -38%
Macquarie Group
37
Macquarie Group
Australia
$42.5M -$15.8M -48,176 -29%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$41.9M – – –
Swiss National Bank
39
Swiss National Bank
Switzerland
$41M – – –
PCIG
40
Partners Capital Investment Group
Massachusetts
$40.7M -$262K -800 -0.7%
Sumitomo Mitsui Trust Group
41
Sumitomo Mitsui Trust Group
Japan
$40.2M -$413K -1,263 -1%
Deutsche Bank
42
Deutsche Bank
Germany
$40.1M +$9.27M +28,346 +35%
CIS
43
Capital International Sarl
California
$38.2M +$2.38M +7,283 +7%
Amundi
44
Amundi
France
$34.4M +$408K +1,249 +1%
CS
45
Credit Suisse
Switzerland
$33.7M +$2.95M +9,028 +11%
UBS Group
46
UBS Group
Switzerland
$31.4M +$12M +36,837 +74%
Vanguard Group
47
Vanguard Group
Pennsylvania
$31M +$233K +714 +0.8%
Baird Financial Group
48
Baird Financial Group
Wisconsin
$30.5M +$1.35M +4,123 +5%
AQR Capital Management
49
AQR Capital Management
Connecticut
$29.4M -$168K -513 -0.6%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$28.9M -$557K -1,704 -2%
1
2
3 4 5

ONC Hedge Fund Activity: Q3 2021 in Review

253 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2021, worth a combined $20.4B — up 6.9% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of ONC and 28 opened new positions — a net loss of 9 holders — while 79 trimmed existing stakes and 97 added.

The largest buyer was Invesco, adding an estimated $190M. The largest seller was Fidelity Investments, cutting an estimated $156M.

  • 253 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2021, down from 266 in Q2 2021.
  • Funds reported $20.4B of BeOne Medicines Ltd stock for Q3 2021, up 6.9% quarter-over-quarter.
  • 28 funds opened new BeOne Medicines Ltd positions in Q3 2021 and 37 closed out, a net change of -9 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2021 was Invesco, an estimated $190M added.
  • The largest BeOne Medicines Ltd seller in Q3 2021 was Fidelity Investments, an estimated $156M sold.

Based on aggregated 13F filings for Q3 2021.